Sandy Lewis
About Sandy Lewis
Sandy Lewis is a Process Technologist at Alkermes plc, a global biopharmaceutical company focused on CNS diseases.
Current Role at Alkermes plc
Sandy Lewis is a Process Technologist at Alkermes plc, a renowned biopharmaceutical company that specializes in Central Nervous System (CNS) diseases. In this capacity, Lewis contributes to the development of innovative medicines aimed at treating various chronic conditions. Alkermes' mission aligns with addressing critical health challenges involving schizophrenia, depression, addiction, and multiple sclerosis.
Previous Experience in Dublin
Prior to their current role, Sandy Lewis served as a Process Technologist at Alkermes' Dublin facility. This experience provided Lewis with a strong foundation in biopharmaceutical processes and an understanding of the operational aspects of drug development and manufacturing within a global company.
Alkermes plc: Company Overview
Alkermes plc is a global biopharmaceutical company committed to the discovery, development, and commercialization of innovative medicines for chronic diseases. The company focuses primarily on CNS diseases, leveraging a diversified commercial product portfolio and a significant clinical pipeline. Alkermes operates research and development centers in Waltham, Massachusetts, and has manufacturing facilities in Athlone, Ireland, and Wilmington, Ohio.
Development of Innovative Medicines
Sandy Lewis is involved in the development of cutting-edge pharmaceutical solutions designed to manage chronic conditions such as schizophrenia, depression, addiction, and multiple sclerosis. This work is part of Alkermes' broader effort to improve patient outcomes and address unmet medical needs within the CNS disease space.